Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tian_Shu Shi"'
Autor:
Ke Lu, Si-Yu Shen, Ou-Yang Luo, Yue Lu, Tian-Shu Shi, Jing Wu, Qi Cheng, Hua-Jian Teng, Di Chen, Xiang Lu, Chao-Jun Li, Qing Jiang, Lei Fang, Bin Xue
Publikováno v:
Cell Death and Disease, Vol 13, Iss 11, Pp 1-13 (2022)
Abstract In the widely used Carbon tetrachloride (CCl4)-induced acute liver injury (ALI) mouse model, hepatocytes are known to die from programmed cell death (PCD) processes including apoptosis and necroptosis. Both in vivo and in vitro experiments s
Externí odkaz:
https://doaj.org/article/81d3ebea510d4cdca3ff54568185165a
Autor:
Shao-Juan Wang, Zi-Min Chen, Min Wei, Jia-Qi Liu, Zong-Lin Li, Tian-Shu Shi, Sheng Nian, Rao Fu, Yang-Tao Wu, Ya-Li Zhang, Ying-Bin Wang, Tian-Ying Zhang, Jun Zhang, Jun-Hui Xiong, Shu-Ping Tong, Sheng-Xiang Ge, Quan Yuan, Ning-Shao Xia
Publikováno v:
Emerging Microbes and Infections, Vol 10, Iss 1, Pp 37-50 (2021)
Hepatitis B e antigen (HBeAg) is a widely used marker both for chronic hepatitis B (CHB) clinical management and HBV-related basic research. However, due to its high amino acid sequence homology to hepatitis B core antigen (HBcAg), most of available
Externí odkaz:
https://doaj.org/article/b4a0b51afac94f5aa4a5cce99d00325f
Autor:
Hua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, Jian Ma, Xiao-Yang Qiao, Tian-Shu Shi, Sheng-Xiang Ge, Hui-Ming Ye, Jun Zhang, Quan Yuan, Tian-Ying Zhang, Ning-Shao Xia
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
To identify drugs that are potentially used for the treatment of COVID-19, the potency of 1403 FDA-approved drugs were evaluated using a robust pseudovirus assay and the candidates were further confirmed by authentic SARS-CoV-2 assay. Four compounds,
Externí odkaz:
https://doaj.org/article/99c6bb154816476bab9f54ea1e62d03a
Autor:
Junhui Xiong, Ningshao Xia, Yangtao Wu, Tianying Zhang, Rao Fu, Sheng Nian, Zonglin Li, Shuping Tong, Shengxiang Ge, Yali Zhang, Min Wei, Tian-Shu Shi, Chen Zimin, Yingbin Wang, Quan Yuan, Jia-Qi Liu, Jun Zhang, Shaojuan Wang
Publikováno v:
Emerging Microbes & Infections
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Hepatitis B e antigen (HBeAg) is a widely used marker both for chronic hepatitis B (CHB) clinical management and HBV-related basic research. However, due to its high amino acid sequence homology to hepatitis B core antigen (HBcAg), most of available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f9d99c971eb44f954f4fae120d3884
https://doi.org/10.1080/22221751.2020.1862631
https://doi.org/10.1080/22221751.2020.1862631
Autor:
Ke Lu, Tian-Shu Shi, Si-Yu Shen, Yong Shi, Hong-Liang Gao, Jing Wu, Xiang Lu, Xiang Gao, Huang-xian Ju, Wei Wang, Yi Cao, Di Chen, Chao-Jun Li, Bin Xue, Qing Jiang
Publikováno v:
Cell metabolism. 34(3)
Hepatic osteodystrophy (HOD) is a metabolic bone disease that is often associated with chronic liver disease and is marked by bone loss. Here, we demonstrate that hepatic expression of the phosphatase PP2Acα is upregulated during HOD, leading to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1f252a16be94662ec4769610fd1037d
https://pubmed.ncbi.nlm.nih.gov/35235770
https://pubmed.ncbi.nlm.nih.gov/35235770
Autor:
Ningshao Xia, Chenguang Shen, Yang Yang, Jun Zhang, Tianying Zhang, Shengxiang Ge, Jian Ma, Tian_Shu Shi, Jiali Cao, Hualong Xiong, Xiao_Yang Qiao, Quan Yuan
To identify drugs that are potentially used for the treatment of COVID-19, the potency of 1403 FDA-approved drugs were evaluated using a robust pseudovirus assay and the candidates were further confirmed by authentic SARS-CoV-2 assay. Four compounds,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17f9c7d8052d6a96cf8a3bd011ef315c
https://doi.org/10.1101/2020.06.05.135996
https://doi.org/10.1101/2020.06.05.135996
Autor:
Ke Lu, Yi-Xuan Li, Tian-Shu Shi, Fei Yu, Si-Cong Min, Liang Qiao, Lan Li, Hua-Jian Teng, Qing Jiang
Publikováno v:
Medicine; 9/29/2017, Vol. 96 Issue 39, p1-5, 5p, 4 Graphs